Chronic obstructive pulmonary disease and glucose metabolism: a bitter sweet symphony.
about
Excess costs of comorbidities in chronic obstructive pulmonary disease: a systematic reviewManaging comorbidities in COPDDiabetic Microvascular Disease and Pulmonary Fibrosis: The Contribution of Platelets and Systemic InflammationCircadian molecular clock in lung pathophysiologyMetabolic Syndrome and the LungIntegrative analysis of DNA methylation and gene expression data identifies EPAS1 as a key regulator of COPD.Visit-to-visit glycemic variability is a strong predictor of chronic obstructive pulmonary disease in patients with type 2 diabetes mellitus: Competing risk analysis using a national cohort from the Taiwan diabetes study.Increased ectodomain shedding of cell adhesion molecule 1 from pancreatic islets in type 2 diabetic pancreata: correlation with hemoglobin A1c levels.Effect of inhaled corticosteroids on glycemic status.Ventilatory function and cardiovascular disease risk factors: a cross-sectional study in young adultsScreening for diabetes mellitus in patients with chronic obstructive pulmonary disease in tertiary care hospital in IndiaThe relation between insulin resistance and lung function: a cross sectional studyMetabolic Effects Associated with ICS in Patients with COPD and Comorbid Type 2 Diabetes: A Historical Matched Cohort Study.The Prevalence of Diabetes Mellitus in COPD Patients with Severe and Very Severe Stage of the DiseaseMetabolic syndrome and chronic obstructive pulmonary disease.Pulmonary Predictors of Incident Diabetes in Smokers.Influence of partial pressure of oxygen in blood samples on measurement performance in glucose-oxidase-based systems for self-monitoring of blood glucose.Pulmonary function reduction in diabetes with and without chronic obstructive pulmonary disease.Comprehensive analysis of circulating adipokines and hsCRP association with cardiovascular disease risk factors and metabolic syndrome in Arabs.Asthma-COPD overlap syndrome showed more exacerbations however lower mortality than COPD.Diabetes risks and outcomes in chronic obstructive pulmonary disease patients: Two nationwide population-based retrospective cohort studies.Chronic obstructive pulmonary disease candidate gene prioritization based on metabolic networks and functional information.Health and disease phenotyping in old age using a cluster network analysis.Systemic tentacles of chronic obstructive pulmonary disease: do we need to account for renal damage?Metabolic syndrome and Chronic Obstructive Pulmonary Disease (COPD): The interplay among smoking, insulin resistance and vitamin D.Metabolic changes of different high-resolution computed tomography phenotypes of COPD after budesonide-formoterol treatment.Prioritizing chronic obstructive pulmonary disease (COPD) candidate genes in COPD-related networks.Body weight and mortality in COPD: focus on the obesity paradox.Obesity and Metabolic Abnormalities in Chronic Obstructive Pulmonary Disease.Metabolic Disorders in Chronic Lung Diseases.Obesity decreases the oxidant stress induced by tobacco smoke in a rat model.Platelet function in diabetic and nondiabetic patients with chronic obstructive pulmonary disease: a case control study.High-sensitivity cardiac troponin in patients with stable chronic obstructive pulmonary disease: looking beyond the lungs.Are laboratory parameter (biomarker) values similar to the healthy volunteer reference range in all patient populations?
P2860
Q26828976-A65CA31E-5B92-47BB-873A-BE35F11D1340Q27005858-266900CF-0B86-4BE1-B0A9-C0E54ADEF56EQ28073977-9569532A-309C-4A83-A59D-9A4D0B186B94Q28082902-3E45EF95-9962-4857-A470-B99AAF0D7913Q28384152-F398D843-DC4E-4716-A0B4-B1DD9155848FQ30883307-75A4F454-B0D2-4533-ACC3-364CA7ACEC98Q33657819-C32B3F71-32B5-48BA-AC00-3376D3604C14Q33806981-99CFFA06-4B1D-4D85-A6FB-58B6A79E6B6CQ35056185-84E7D9AE-1CAD-4152-A48A-8F39DB9DEAAEQ35060331-133E108E-947C-4D10-92F1-89682EDC89E8Q35244561-42AC3A7A-B8F7-434E-85FD-7CB0921D377CQ35834123-A5FEBF54-BE74-415F-801B-914408CCE22EQ36141290-929C1843-C521-4C1D-8516-CDB114A66BDFQ37006598-ED3FCA86-D2D0-41C6-BF89-DEB2614146E3Q37102124-496EE6FA-8EE6-434C-83A0-670096BE2874Q37375728-B348A7BD-C254-4755-91D0-56E31874CA76Q37421575-3A5DBD2F-CA99-4AEA-A8A5-DC8B79773DC2Q37504119-1692A764-550B-4418-A710-78212FA6568BQ37719348-E5991245-E6CE-4022-B575-4EF1AC483F0FQ39013689-BF1A1960-8A06-4C10-9DD0-E3491525340FQ41432972-856582B2-D785-4BB8-A1DB-AAF69B8CBAF4Q41616141-8BE1BD8A-4F18-4BC0-92ED-7A86F5718593Q45119050-E36CC157-2FD1-4E4B-B285-71E845F28BEAQ45711435-E87760F5-C774-469A-9400-DAC2D9746323Q45793325-2E5FC9EA-CC53-4FA7-8099-88844FC546D5Q47103106-F7CA1BCF-36AB-4147-9E35-067781E10081Q47113578-ACFE07FA-9D43-48DA-A066-5FD2C8AF6FC2Q47177659-7994FEDA-A851-4B03-A425-6D94647C7055Q47704314-321946EB-747F-42C1-8F98-F843AD3E91A0Q49795481-413D9DAC-C47D-484D-BE0F-6C02FC68DDA2Q52973167-CBDA4B6A-FDE0-4A53-A6AA-CB017C6B1CDBQ53768286-81B79A34-B359-4D33-A2C7-0CBE81EFBBB3Q54513472-322FA4BA-95CC-4CBC-BD6C-A943C18A38E1Q58761610-0BCE32A9-FE38-40A8-8DBC-B0B28CFD24A7
P2860
Chronic obstructive pulmonary disease and glucose metabolism: a bitter sweet symphony.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Chronic obstructive pulmonary disease and glucose metabolism: a bitter sweet symphony.
@ast
Chronic obstructive pulmonary disease and glucose metabolism: a bitter sweet symphony.
@en
type
label
Chronic obstructive pulmonary disease and glucose metabolism: a bitter sweet symphony.
@ast
Chronic obstructive pulmonary disease and glucose metabolism: a bitter sweet symphony.
@en
prefLabel
Chronic obstructive pulmonary disease and glucose metabolism: a bitter sweet symphony.
@ast
Chronic obstructive pulmonary disease and glucose metabolism: a bitter sweet symphony.
@en
P2860
P921
P356
P1476
Chronic obstructive pulmonary disease and glucose metabolism: a bitter sweet symphony.
@en
P2093
Aibek E Mirrakhimov
P2860
P2888
P356
10.1186/1475-2840-11-132
P407
P5008
P577
2012-10-27T00:00:00Z
P5875
P6179
1038406907